Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 1
1998 1
1999 2
2000 2
2002 1
2004 1
2005 1
2012 3
2013 7
2014 5
2015 5
2016 9
2017 9
2018 9
2019 10
2020 11
2021 7
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. Among authors: kulkarni hr. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results.
Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, Mueller D, Eismant A, Almaguel F, Zboralski D, Osterkamp F, Hoehne A, Reineke U, Smerling C, Kulkarni HR. Baum RP, et al. Among authors: kulkarni hr. J Nucl Med. 2022 Mar;63(3):415-423. doi: 10.2967/jnumed.120.259192. Epub 2021 Jun 24. J Nucl Med. 2022. PMID: 34168013 Free PMC article.
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.
Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schäfers M, Essler M, Baum RP, Kulkarni HR, Schmidt M, Drzezga A, Bartenstein P, Pfestroff A, Luster M, Lützen U, Marx M, Prasad V, Brenner W, Heinzel A, Mottaghy FM, Ruf J, Meyer PT, Heuschkel M, Eveslage M, Bögemann M, Fendler WP, Krause BJ. Rahbar K, et al. Among authors: kulkarni hr. J Nucl Med. 2017 Jan;58(1):85-90. doi: 10.2967/jnumed.116.183194. Epub 2016 Oct 20. J Nucl Med. 2017. PMID: 27765862 Free article.
Theranostics of Neuroendocrine Tumors.
Lee ST, Kulkarni HR, Singh A, Baum RP. Lee ST, et al. Among authors: kulkarni hr. Visc Med. 2017 Oct;33(5):358-366. doi: 10.1159/000480383. Epub 2017 Oct 20. Visc Med. 2017. PMID: 29177165 Free PMC article. Review.
Precision Imaging of Prostate Cancer.
Kulkarni HR, Alavi A. Kulkarni HR, et al. PET Clin. 2022 Oct;17(4):xiii. doi: 10.1016/j.cpet.2022.07.010. PET Clin. 2022. PMID: 36229107 No abstract available.
[Pulmonary neuroendocrine neoplasms].
Sayeg Y, Sayeg M, Baum RP, Kulkarni HR, Presselt N, Mäder I, Kunze A, Sänger J, Hörsch D, Bonnet R. Sayeg Y, et al. Among authors: kulkarni hr. Pneumologie. 2014 Jul;68(7):456-77. doi: 10.1055/s-0034-1365642. Epub 2014 Jul 9. Pneumologie. 2014. PMID: 25006841 Free article. Review. German.
80 results